EUVIMEDEUVIMED entdecken
Crossref

Green Ultra‐Fast UPLC–MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability

Mohamed W Attwa iD, Ali S Abdelhameed iD, Awadh M Ali iD, Haitham AlRabiah, Adnan A Kadi

Biomedical Chromatography · 2026

DOI: 10.1002/bmc.70297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Mohamed W Attwa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Triazines, Aminopyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: The Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enasidenib (ESD), an oral medication, was used for the treatment of patients with refractory or relapsed Acute Myeloid Leukemia. No prior UPLC‐MS/MS method with combined green metrics and in silico metabolism analysis for ESD was reported, so the research sought to establish an ultrafast UPLC‐MS/MS method for estimating ESD in the HLMs matrix. The MS/MS analysis was applied applying positive ESI ionization mode, and chromatography using an Eclipse Plus C8 column (reversed phase) within one minute. The UPLC‐MS/MS method exhibited a good degree of greenness as approved by the MoGAPI score (68.0) and the AGREE score (0.66). The linearity range was form 1 ng/mL (LOQ) to 4000 ng/mL. The precision and accuracy for intraday and interday measurements varied from −3.11% to 10.67% and −7.22% to 12.33%, respectively. The in vitro t 1/2 and the intrinsic clearance (Cl int ) were determined to be 82.52 min (long) and 9.83 mL/min/kg (low), respectively that is considered a low clearance drug. Slight structural modifications to the 2‐methyl propan‐2‐ol moiety and pyridine ring in drug design could upsurge the ESD metabolic stability. The combined in vitro/in silico method delivers a resource‐efficient strategy for early‐stage metabolic screening and progressing innovative drug research focused on improving metabolic stability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryTriazinesAminopyridinesChromatography, High Pressure LiquidHumansReproducibility of ResultsLinear ModelsComputer SimulationLimit of DetectionLeukemia, Myeloid, AcuteDrug StabilityMicrosomes, LiverAnimalsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

DEREK moduleEnasidenibP450 metabolic softwareStarDrop software packageUPLC‐MS/MSin vitro metabolic stability

Substanzen

TriazinesenasidenibAminopyridines

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

ORCID-Profile: Mohamed W Attwa, Ali S Abdelhameed, Awadh M Ali

Förderung

  • The Ongoing Research Funding program at King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Attwa, M. W., Abdelhameed, A. S., Ali, A. M., AlRabiah, H., & Kadi, A. A. (2026). Green Ultra‐Fast UPLC–MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability. Biomedical Chromatography. https://doi.org/10.1002/bmc.70297

Vancouver

Attwa MW, Abdelhameed AS, Ali AM, AlRabiah H, Kadi AA. Green Ultra‐Fast UPLC–MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability. Biomedical Chromatography. 2026. doi:10.1002/bmc.70297

BibTeX
@article{Attwa2026,
  author = {Attwa, Mohamed W and Abdelhameed, Ali S and Ali, Awadh M and AlRabiah, Haitham and Kadi, Adnan A},
  title = {Green Ultra‐Fast UPLC–MS/MS Method for Enasidenib Quantification in HLMs Matrix With the Metabolic Stability Assessment: In Silico Study for Structural Alerts, ADME Characteristics and Metaboslic Lability},
  journal = {Biomedical Chromatography},
  year = {2026},
  doi = {10.1002/bmc.70297}
}
Kostenlos starten →